AIHTA - Publications - Search - Microwave ablation for liver tumours

Vandepeer, M. and Forel, D. and Nicolopoulos, K. and Rochet, E. and Ali, A. and Duncan, J. and Goetz, G. (2022): Microwave ablation for liver tumours. Decision Support Document 131.

[thumbnail of DSD_131.pdf]
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

Microwave ablation (MWA) uses electromagnetic energy to heat and destroy tumours. It is used under local or general anaesthesia, either percutaneously, laparoscopically or as part of open surgery for primary hepatocellular (HCC), but also secondary liver carcinomas.

Given the available evidence (12 RCTs), MWA appears to be comparable to radiofrequency ablation (RFA) for the treatment of early-stage HCC. Further clinical trials and robust RCTs are needed to evaluate the efficacy and safety of MWA compared to other treatments for early-stage HCC, as well as the use of MWA to treat other types of primary and secondary liver cancer.

Item Type:Decision Support Document
Keywords:Liver cancer, hepatocellular carcinoma, minimally-invasive surgery, microwave ablation, thermic ablation
Subjects:QZ Pathology > QZ 200-380 Neoplasms.Cysts
W Health professions > W 100-275 Medical, dental and pharmaceutical service plans
WB Practice of medicine > WB 300-962 Therapeutics
WI Digestive system > WI 700-770 Liver. Billary tract
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WO Surgery > WO 505 Minimally invasive surgical procedures
Series Name:Decision Support Document 131
Deposited on:15 Jul 2022 09:47
Last Modified:15 Jul 2022 09:47

Repository Staff Only: item control page